TGA Approval

SCEMBLIX asciminib (as hydrochloride) 40 mg film-coated tablet blister pack (371018)

ARTG ID

371018

ARTG Name

SCEMBLIX asciminib (as hydrochloride) 40 mg film-coated tablet blister pack

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

July 15, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-01714-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01713-1

Ingredient Name

asciminib hydrochloride

Empowering clinical research with data-driven insights and AI-powered tools.

SCEMBLIX asciminib (as hydrochloride) 40 mg film-coated tablet blister pack (371018) - TGA 批准文号 | MedPath